Laboratory Corporation of America Holdings (LabCorp) Is Scheduled to Present at the William Blair & Company Personalized Medicine Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that Andrew J. Conrad, Ph.D., Chief Scientist and David M. Johnston, Ph.D., Vice President and Global Head of Clinical Trials, are scheduled to speak at the William Blair & Company Personalized Medicine Conference in New York. LabCorp’s presentation is planned for Thursday, August 6, 2009.
MORE ON THIS TOPIC